T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

NCT01621477 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

OTHER

Sponsor class

Stopped Study was terminated in August 2016 due to replacement by a new study.

Conditions

Acute Lymphoblastic Leukemia
Acute Myelocytic Leukemia
Chronic Myelocytic Leukemia
Juvenile Myelomonocytic Leukemia
Myelodysplastic Syndrome
Hodgkin or Non-Hodgkin Lymphoma
Sarcoma, Myeloid

Interventions

DRUG: clofarabine
DRUG: cytarabine
DRUG: busulfan
DRUG: Plerixafor
DRUG: cyclophosphamide
DRUG: antithymocyte globulin (rabbit)
BIOLOGICAL: stem cells
DRUG: Tacrolimus
DRUG: mycophenolate mofetil

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]